Zikun Ma
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Cancer Cells and Metastasis
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Clinical Psychology top 10%
- COVID-19 and Mental Health
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
-
- Immune cells in cancer 3
- Co-authors
- Zhuo-wei Liu (10 shared papers)Yize Mao (6 shared papers)Jie Jun Cheng (5 shared papers)Xiangdong Li (2 shared papers)Xiaoyu Liang (2 shared papers)Wei Chen (1 shared paper)Jianhua Yin (3 shared papers)Zhuoli Huang (2 shared papers)
- Journals
- Cancer Cell (3 papers)Medicine (3 papers)Cell Reports (2 papers)Annals of Laboratory Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Zikun Ma
18 papers receiving 695 citations
Zikun Ma's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 217
- Clinical Psychology 129
- Pathology and Forensic Medicine 96
- Surgery 141
- Immunology 59
Countries citing papers authored by Zikun Ma
This map shows the geographic impact of Zikun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zikun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zikun Ma more than expected).
Fields of papers citing papers by Zikun Ma
This network shows the impact of papers produced by Zikun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zikun Ma. The network helps show where Zikun Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Zikun Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 223 | |
| 2 | Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer Hit paper breakdown → | 2022 | 190 |
| 3 | 2017 | 111 | |
| 4 | 2023 | 38 | |
| 5 | 2016 | 20 | |
| 6 | 2019 | 18 | |
| 7 | 2020 | 15 | |
| 8 | 2017 | 14 | |
| 9 | 2019 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 11 | |
| 12 | 2023 | 10 | |
| 13 | 2024 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2025 | 6 | |
| 16 | 2022 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2026 | 3 | |
| 19 | 2026 | 0 | |
| 20 | 2026 | 0 |
About Zikun Ma
Zikun Ma is a scholar working on Oncology, Immunology, Surgery, Cancer Research and Clinical Psychology, having authored 21 papers that have together received 707 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Scoliosis diagnosis and treatment (3 papers), Clinical Laboratory Practices and Quality Control (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cervical and Thoracic Myelopathy (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers) and COVID-19 and Mental Health (2 papers). The work is most often cited by research in Oncology (217 citations), Clinical Psychology (129 citations), Pathology and Forensic Medicine (96 citations), Surgery (141 citations) and Immunology (59 citations). Zikun Ma has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Zhuo-wei Liu, Yize Mao, Jie Jun Cheng, Xiangdong Li, Xiaoyu Liang, Wei Chen, Jianhua Yin, Zhuoli Huang, Guibo Li and Chaofeng Li. Their work appears in journals such as Cancer Cell, Medicine, Cell Reports, Annals of Laboratory Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.